Investigation of the KIR-status of patients with head and neck squamous-cell carcinoma in bloodserum

Introduction The activation of natural killer cells (NK) by their KIR (killer cell immunoglobulin-like receptor) is a potent defense system of tumor cells. In this thesis we want to investigate the profile of 16 inhibiting and activating KIRs in bloodserum of patients with a head and neck squamous-cell carcinoma (HNSCC). Furthermore, we calculate the correlation between the KIR-status and the overall survival (OS) of HNSCC-patients.

Methods Therefore, we isolated free circulating DNA of 205 HNSCC serum samples, including 16 patients with a relapse and of 52 health control samples and detected the KIR-genes qualitative by realtime-PCR. The correlation between KIR-status and OS was tested univariately by Kaplan-Meier analysis and log-rank-test.

Results Using known KIR-profiles it was demonstrated that the analysis of the KIR-status from serum samples was possible. We found a significant correlation between the expression of KIR2DL5 (p=0,017), as well as the expression of KIR2DS1 (p=0,027) and the OS of HNSCC-patients. The survival time was prolonged by the presence of KIR2DL5 or KIR2DS1. Moreover, there was a statistically significant difference between the frequency of KIR2DL1 in the HNSCC group (p=0,001), the control group (p=0,028) and the previously described frequency for Germany. There were no statistically significant correlations for the remaining KIRs found.

Conclusion It could be shown that KIR2DL5 or KIR2DS1 associates with a better OS of HNSCC-patients. This leads us to the conclusion that these receptors may have an important impact on the tumor-specific effect of NK cells. Further studies are needed to clarify the biological mechanisms underlying this survival difference.

 

MissingLinkText

Conflict of Interest

The author declares that there is no conflict of interest.

Publikationsverlauf

Artikel online veröffentlicht:
24. Mai 2022